financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Reiterates Sell Opinion On Shares Of The Macerich Company
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Reiterates Sell Opinion On Shares Of The Macerich Company
Apr 30, 2024 11:31 AM

02:05 PM EDT, 04/30/2024 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

After the earnings miss, we lower our target by $2 to $12, on forward P/FFO of 7.0x our 2024 FFO estimate, a discount to retail REIT peers (12.3x) due to MAC's high leverage profile (net debt to EBITDA of 9.5x). We cut our 2024 FFO estimate by $0.09 to $1.71 and 2025's by $0.10 to $1.74. MAC reported Q1 2024 FFO of $0.31 vs. $0.40, a $0.08 consensus miss. MAC also scrapped 2024 guidance, while undergoing a strategic review of how best to bring leverage down to more manageable levels (low 6's range) over next few years, which likely includes increased dispositions and/or additional equity issuance. Rental revenues dropped 3% Y/Y with same-store NOI excluding lease terminations, down 2% Y/Y. Portfolio occupancy improved to 93.4% vs. 92.2% Y/Y as overall leasing remains strong. Yet, we expect occupancy to face headwinds from here due to the recently announced Express bankruptcy. MAC has kept variable rate debt modest at 8% of total debt, but it has significant maturities due in 2024 ($403M) and 2025 ($1.1B).

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Buy Opinion On Shares Of Eli Lilly And Company
Research Alert: CFRA Keeps Buy Opinion On Shares Of Eli Lilly And Company
May 25, 2025
01:30 PM EDT, 05/01/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our target price to $973 from $1,045, on 33.2x our 2026 EPS estimate, a discount to LLY's five-year historical forward P/E average. We cut our 2025 EPS estimate...
Research Alert: CFRA Maintains Sell Opinion On Shares Of Penske Automotive Group Inc.
Research Alert: CFRA Maintains Sell Opinion On Shares Of Penske Automotive Group Inc.
May 25, 2025
01:05 PM EDT, 05/01/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target to $120 from $140 on a 2026 P/E of 8.5x, a discount to PAG's five-year average forward P/E of 9.4x. We lower our adjusted EPS...
Research Alert: CFRA Raises Opinion On Shares Of Harley-davidson, Inc. To Hold From Sell
Research Alert: CFRA Raises Opinion On Shares Of Harley-davidson, Inc. To Hold From Sell
May 25, 2025
03:05 PM EDT, 05/01/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We increase our 12-month target by $4 to $24, based on a 2026 P/E of 7.0x, a steep but justified discount to historic averages. We lower our EPS estimates to...
Research Alert: CFRA Keeps Hold Opinion On Shares Of Loblaw Companies Limited
Research Alert: CFRA Keeps Hold Opinion On Shares Of Loblaw Companies Limited
May 25, 2025
02:00 PM EDT, 05/01/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target price to CAD229 from CAD188, based on 22x our 2026 EPS estimate of CAD10.42 (up from CAD10.07). We also raise our 2025 EPS estimate to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved